Your browser doesn't support javascript.
loading
Azacitidine to Consolidate and Deepen the Therapeutic Response Achieved by Intensive Induction Treatment in a Young Patient Affected by NPM1mut-AML Who Has Become Ineligible for High-Dose Consolidation.
Cenfra, Natalia; Lapietra, Gianfranco; Perrone, Salvatore; Voso, Maria Teresa; Divona, Mariadomenica; Mecarocci, Sergio; La Barbera, Elettra Ortu; Cimino, Giuseppe.
Afiliación
  • Cenfra N; Hematology Polo Universitario Pontino, S.M. Goretti Hospital, Latina, Italy.
  • Lapietra G; Department of Translational and Precision Medicine University "La Sapienza", Rome, Italy.
  • Perrone S; Hematology Polo Universitario Pontino, S.M. Goretti Hospital, Latina, Italy.
  • Voso MT; Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy.
  • Divona M; Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy.
  • Mecarocci S; Hematology Polo Universitario Pontino, S.M. Goretti Hospital, Latina, Italy.
  • La Barbera EO; Hematology Polo Universitario Pontino, S.M. Goretti Hospital, Latina, Italy.
  • Cimino G; Hematology Polo Universitario Pontino, S.M. Goretti Hospital, Latina, Italy.
Chemotherapy ; 67(1): 24-28, 2022.
Article en En | MEDLINE | ID: mdl-35021172

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Azacitidina / Leucemia Mieloide Aguda Tipo de estudio: Diagnostic_studies Límite: Adult / Aged / Humans Idioma: En Revista: Chemotherapy Año: 2022 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Azacitidina / Leucemia Mieloide Aguda Tipo de estudio: Diagnostic_studies Límite: Adult / Aged / Humans Idioma: En Revista: Chemotherapy Año: 2022 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Suiza